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Abstract
A comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry (GC×GC–TOF-MS) experimental setup was
tested for the measurement of seven 2,3,7,8-substituted polychlorinated dibenzo-p-dioxins (PCDDs), ten 2,3,7,8-substituted polychlorinated
dibenzofurans (PCDFs), four non-ortho-polychlorinated biphenyls (PCBs), eight mono-ortho-PCBs, and six indicator PCBs (Aroclor 1260)
in foodstuff samples. A 40m RTX-500 (0.18mm I.D., 0.10mm df) was used as the first dimension (1D) and a 1.5m BPX-50 (0.10mm
I.D., 0.10mm df) as the second dimension (2D). The GC×GC chromatographic separation was completed in 45min. Quantification was
performed using 13C-label isotope dilution (ID). Isotope ratios of the selected quantification ions were checked against theoretical values
prior to peak assignment and quantification. The dynamic working range spanned three orders of magnitude. The lowest detectable amount
of 2,3,7,8-TCDD was 0.2 pg. Fish, pork, and milk samples were considered. On a congener basis, the GC×GC–ID-TOF-MS method was
compared to the reference GC-ID high resolutionmass spectrometry (HRMS)method and to the alternative GC-ID tandem-in-time quadrupole
ion storage mass spectrometry (QIST-MS/MS). PCB levels ranged from low picogram (pg) to low nanogram (ng) per gram of sample and
data compared very well between the different methods. For all matrices, PCDD/Fs were at a low pg level (0.05–3 pg) on a fresh weight
basis. Although congener profiles were accurately described, RSDs of GC×GC–ID-TOF-MS and GC–QIST-MS/MS were much higher than
for GC–ID-HRMS, especially for low level pork and milk. On a toxic equivalent (TEQ) basis, all methods, including the dioxin-responsive
chemically activated luciferase gene expression (DR-CALUX) assay, produced similar responses. A cost comparison is also presented.
© 2005 Elsevier B.V. All rights reserved.
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1. Introduction
The measurement of selected polychlorinated dibenzo-p-
dioxin (PCDD), polychlorinated dibenzofuran (PCDF), and
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polychlorinated biphenyl (PCB) concentrations at the ultra-
trace level in biological matrices is a challenge for analysts.
The main reasons are obviously the low levels to measure
(parts-per-billion [ppb] to parts-per-quadrillion [ppq]) and
the large number of compounds to consider (>35 out of a
total of >400). However, an additional major difficulty is
the implementation of efficient sample pre-treatment prior
to measurement. Foodstuffs are of prime interest because
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they are responsible for more than 95% of human intake and,
therefore, subject to strict regulation [1].
As 2,3,7,8-substituted PCDD/Fs (the toxic congeners [2])
and dioxin-like PCBs (non- and mono-ortho-substituted) are
lypophilic compounds, they tend to bio-accumulate in fat up
at the higher end of the food chain. Consequently, analysts
have to be able to extract the analytes from the lipid com-
partment and remove as manymatrix-related interferences as
possible prior to gas chromatography (GC) analysis. Several
approaches exist and necessitate the use of state-of-the-art
extraction techniques, as well as automated preparative chro-
matography instrument [3,4].
Classically, GC coupled to 13C-labelled isotope dilu-
tion (ID) sector high-resolution mass spectrometry (HRMS)
is used for accurate identification and measurement of
PCDD/Fs andPCBs in cleaned extracts [5].Due to highfinan-
cial investment, high operating cost, and high qualification
requirements for operators, alternative approaches have been
investigated during recent years. The European Union distin-
guishes reference methods from screening methods [6]. The
only reference method is GC–ID-HRMS using sector instru-
ments. Screening methods can still be based on MS instru-
ments or may consist of bioassays or immunoassays. In the
mass spectrometric area, the most studied alternative method
is GC coupled to bench-top low resolution quadrupole ion
storagemass spectrometry (QIST-MS) [7,8]. The loss inmass
resolution is counter-balanced by a gain in specificity by oper-
ating the QIST-MS in tandem mode. Specificity is ensured
by the monitoring of daughter ions issued from the partic-
ular fragmentation of target parent ions [9]. The sensitivity
is high enough to allow analyses at similar levels to HRMS
[10,11].BecauseHRMSandQIST-MSperform, respectively,
in selected ion monitoring (SIM) and in multiple reaction
monitoring (MRM) mode, chromatograms have to be split in
time windows, for which different SIM descriptor ions are
defined. Although SIM improves instrument sensitivity, its
major drawback is the necessity of redefining SIM windows
every time the chromatographic parameters are modified.
This risks themissing of compounds that are no longer in their
time window. Additionally, because of scan rate limitations,
the SIM approach is not compatible with the measurement
of a large number of compounds characterized by different
masses inside the same window.
Time-of-flight mass spectrometry (TOF-MS) offers the
advantage of a comprehensive mass analysis in a broad
dynamic range [12]. Because TOF-MS is a non-scanning
technique, all ions included in the mass range are virtually
recorded at the same time and are represented at the same
point on the chromatographic peak profile. Constant ion ratio
across theGC peak is thus ensured. High qualitymass spectra
are produced and deconvoluted if more than one compound
is present at the time mass spectra are recorded, as is the case
when two compounds chromatographically co-elute. How-
ever, GC–TOF-MS has relatively poor instrumental limits
of detection (LODs), compared with HRMS and QIST-MS.
One solution to improve these LODs is to operate in fast
GC (FGC) mode. The resulting peak compression conducts
somewhat more intense (narrower) peaks and, in practice,
instrumental LODs of 0.5 pg have been reported in the case
of PCBs [13]. However, in the case of PCDD/Fs, such an
FGC approach would both compromise the already limited
chromatographic resolution (observed, for example, in the
case of hexa-chlorinated congeners), and lead to undesirable
co-elution problems.
Because it also offers zone compression of chromato-
graphic peaks while improving the peak capacity of the sep-
aration system, comprehensive two-dimensional gas chro-
matography (GC×GC) [14,15], represents a potential solu-
tion to enhance the sensitivity TOF-MS without scarifying
chromatographic resolution. In the case of PCBs, it has been
reported thatLODsof aGC×GC–TOF-MSsystemcanbeup
to 10-times lower than its GC–TOF-MS equivalent and be in
the range of 0.2–0.5 pg injected [16]. GC×GC–ID-TOF-MS
has recently been successfully used to analyze soil and ashes
for PCDD/Fs [17], but also to measure a large set of analytes
consisting of a mixture of 38 PCBs, 11 OCPs (organochlo-
rine pesticides), and 10 PBDEs (polybrominated diphenyl
ethers) in human body fluids [18]. All analytes (and their cor-
responding 13C-labels) were separated chromatographically
or by mean of mass spectral deconvolution.
MS based screening methods have to fulfill the same
requirements as GC–HRMS in terms of the following: ID
standards used, spiking, control of recovery rates, and GC
separation. Cell-based bioassays, on the other hand, have
to comply with specific requirements regarding the use of
reference samples, calibration, precision, and LODs [6]. Cur-
rently, one of the assays that fits bestwith the requirements for
the screening of dioxins and dioxin-like PCBs in foodstuffs
is the dioxin-responsive chemical-activated luciferase gene
expression (DR-CALUX) bioassay [19]. Like its CALUX
homologue [20] based on mouse cell lines, it uses geneti-
cally modified rat cell lines into which the firefly luciferase
gene has been incorporated and is under the control of the
aryl hydrocarbon (Ah) receptor. This is the receptor to which
xenobiotics, such as some dioxins and PCBs, bind once in the
cellmedia [21]. The quantity of dioxins and PCBs present in a
sample extract submitted for bio-testing is estimated in terms
of the luminescence that results from the enzymatic activity
of the firefly luciferase produced. Details on the basics of the
bio-assay approach are available elsewhere [22].
The present study focused on the development and testing
of a GC×GC–ID-TOF-MS method for the measurement of
selected PCDD/Fs and PCBs in foodstuffs for which regula-
tory levels have been set by the European Union [1]. The set
of compounds consisted of seven 2,3,7,8-substituted PCDDs,
ten 2,3,7,8-substituted PCDFs, four non-ortho-PCBs, eight
mono-ortho-PCBs, and six indicator PCBs (Aroclor 1260),
from a total of 35 compounds. GC×GC–ID-TOF-MS
results were compared to the confirmatory reference GC–ID-
HRMS method, to the alternative screening GC–ID-QIST-
MS/MS method, and to the DR-CALUX bioassay screening
method.
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2. Experimental
2.1. Chemicals
All solvents were Pestanal reagents (Riedel-de Hae¨n,
Seelze, Germany). Nonane puriss analytical-reagent grade,
standard for GC, was purchased from Fluka (Steinheim,
Germany). Sodium sulfate anhydrous was Baker-analyzed
(J.T. Baker, Deventer, The Netherlands). Liquid nitrogen
was purchased from Air Liquide (Liege, Belgium). Chro-
matographic pure grade helium gas, 99.9999%, was pur-
chased fromAir Products (Vilvoorde, Belgium). The internal
standard solution of the seventeen 2,3,7,8-chloro-subsituted
13C12 congeners labeled PCDD/Fs (EDF-4144), the calibra-
tion standard solution (EDF-4143), and the syringe (recov-
ery) standard (EDF-4145) were purchased from Cambridge
Isotope Laboratory (Andover, MS, USA). The EDF-4143,
EDF-4144, and EDF-4145 concentrations of the native and
labeled congeners are summarized in a previous report [23].
The 13C12-labelled PCB internal standard spiking solution
(EC-5023), as well as the 10-point calibration solutions (EC-
5022),were obtained fromCIL. For PCDD/Fs andnon-ortho-
PCBs, a mixture of [13C]TeCB-80, [13C6]1,2,3,4-TeCDD,
and [13C]1,2,3,4,7,8,9-HpCDFwas used as the recovery stan-
dard. Non-ortho-PCB recovery rates were calculated against
13C-TeCB-80. TeCDD/F and PeCDD/F recovery rates
were calculated against [13C6]1,2,3,4-TeCDD. HxCDD/F,
HpCDD/F, OCDD/F recovery rates were calculated against
[13C]1,2,3,4,7,8,9-HpCDF. For mono-ortho-PCBs and indi-
cator PCBs, 13C-TeCB-80 was used as the recovery stan-
dard. Details on MS standards are available elsewhere [24].
The bioassay 2,3,7,8-TeCDD standard solution in DMSO
(dimethyl sulfoxide) (purity >98%) came from Wellington
Labs. (Campro Scientific, Veenendaal, The Netherlands).
2.2. Sample preparation
Biological samples consisted of fish, pork, and cow’s
milk. Fish samples were filleted and minced North Sea her-
ring. All samples were part of the dioxins in food and feed
– reference methods and new certified reference materials
(DIFFERENCE)European project [25]. Sampleswere issued
from homogenized pools and canned in sub-samples prior to
shipping to the laboratory. Samples were analyzed twice in
triplicate (in two independent series). Except for the bioassay,
internal 13C-labelled standards were added prior to extrac-
tion. Recovery standards were added to the GC vials prior to
injection. Beef fat and milk QC samples, as well as method
blanks, were incorporated into a series of unknowns. Further-
more, for the bioassay, for each biological sample, a reference
sample was available and analyzed by both GC–ID-HRMS
and DR-CALUX.
2.2.1. Sample preparation for mass spectrometric analysis
2.2.1.1. PCDD/Fs and dioxin-like PCBs. Fish sampleswere
mixed with sodium sulfate (2 equivalent in weight) prior
to extraction by pressurized liquid extraction (PLE) using
a Dionex ASE 200 extractor (Sunnyvale, CA, USA). Hex-
ane was used, 20ml of hexane per cycle, 5min cycle time,
2 cycles per extraction, pressure of 1500 psi. Extracts were
dried byfiltration through sodium sulfate, evaporated at 40 ◦C
using a rotary evaporator (Laborota 4000, Heildolph, VWR
International, Leuven, Belgium). The extractable lipid con-
tent was determined gravimetrically and the fat was diluted
in 50ml of hexane prior to further clean-up. The sample sizes
were 15 g. Pork samples were mixed with sodium sulfate (3
equivalent in weight) prior to extraction by PLE and received
identical treatment to the fish samples. Sample sizes ranged
between 31 and 33 g. Whole milk samples were sonicated
at 35 ◦C for 30min and then Liquid–liquid extracted with
a mixture of ethanol, ammoniac, diethyl ether, and hexane
(4:1:5:5) for 30min. Sample sizes ranged between 100 and
130 g. As for fish and pork, extracts were dried for lipid
determination and a final volume of 50ml of hexane was
obtained.
Sample clean-up was carried out using an auto-
mated system (Power-Prep, Fluid Management Systems,
Waltham, MA, USA) [4]. The disposable column sets
were made of multi-layer (acidic, basic and neutral) sil-
ica columns, basic alumina columns, and carbon-celite
columns. The mono-ortho-PCB fraction was collected when
flushing the carbon column in a forward direction with a
hexane–dichloromethane mixture (1:1). The PCDD/F and
non-ortho-PCB fractions were collected when back-flushing
the carbon column with toluene. Details of the fraction-
ation procedure have been reported previously [23,26,27].
Cleaned extracts were evaporated using a Turbovap II work-
station (Zymark, Paris, France) after the addition of 10ml
(PCDD/Fs and non-ortho-PCBs) and 20ml (mono-ortho-
PCBs) of nonane. For GC–ID-HRMS injections, final vol-
umeswere 10ml (PCDD/Fs and non-ortho-PCBs) and 100ml
(mono-ortho-PCBs). Extracts were stored in GC vials at
−20 ◦C prior to GC–MS injection.
2.2.1.2. Indicator PCBs. Fish and pork samples (1.2–1.7 g)
were treated as follows: Water and isopropanol (3ml each)
were added to the sample. Liquid–liquid extraction was car-
ried out with 10ml of a mixture of diethyl ether–hexane
(3:97). Two extraction cycles with 30min shaking each were
performed at room temperature. Extracts were filtered on
sodium sulfate (1 g) and evaporated to 2ml under a gentle
stream of nitrogen. Whole milk samples (7 g) were soni-
cated at 35 ◦C for 30min and then liquid–liquid extracted
with a mixture of ethanol, ammoniac, diethyl ether, and hex-
ane (4:1:5:5) for 30min. Extracts were filtered on sodium
sulfate (1 g) and evaporated to 2ml under a gentle stream of
nitrogen.
Sample clean-up was carried out according to the Bel-
test I014 method [28]. From top to bottom, the open column
was made of 0.5 g of sodium sulfate, 1 g of deactivated alu-
mina, and 4 g of acidic silica. Hexane was used as the solvent
(twice 10ml). Cleaned extracts were evaporated using a Tur-
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bovap II workstation after the addition of 20ml of nonane.
For GC–ID-HRMS injections, final volumes were 100ml.
Extracts were stored in GC vials at −20 ◦C prior to GC–MS
injection.
2.2.2. Sample preparation for DR-CALUX analysis
Fish and pork samples (30 g) were treated as follows:
Water and isopropanol (45ml each) were added to the sam-
ple. Liquid–liquid extraction was carried out with 90ml of
a mixture of diethyl ether–hexane (3:97). Three extraction
cycles were performed at room temperature (60min shaking,
once, followed by 30min shaking, twice). After the addition
of sodium sulfate (1 g) and filtration on silane treated glass
wool, the extracts were evaporated to dryness at 40 ◦C using
a rotary evaporator (Laborota 4000, Heildolph, VWR Inter-
national, Leuven, Belgium). Whole milk samples (150 g)
were sonicated at 35 ◦C for 30min and then Liquid–liquid
extracted with 450ml of a mixture of ethanol, ammoniac,
diethyl ether, and hexane (4:1:5:5) for 30min. Extracts were
filtered on sodium sulfate (1 g) and evaporated to dryness.
The fat weight was determined, and 2 g of fat was used for
the clean-up.
Sample clean-up was carried out according to the method
proposed by BioDetection System (BDS) [29], slightly mod-
ified. From top to bottom, the open column consisted of 2 g
of sodium sulfate, 20 g of 20% sulfuric acidic/silica, 20 g
of 33% sulfuric acidic/silica and glass wool. Hexane/diethyl
ether (97:3) was used as a solvent (135ml). Cleaned extracts
were evaporated using a Turbovap II workstation. Just before
completing evaporation of the solvent, DMSO was added
and the remaining solvent was evaporated under a gen-
tle stream of nitrogen. In the case of method blanks, the
same procedure was applied to the solvent instead of the
sample.
2.3. Measurement
2.3.1. GC–ID-HRMS
2.3.1.1. PCDD/Fs and non-ortho-PCBs. Concentrations
were measured on an Autospec Ultima (Micromass, Manch-
ester, UK) coupled to an Agilent 6890 Series (Palo Alto,
CA, USA) gas chromatograph equipped with an A200SE
autosampler (CTC Analytics, Zwingen, Switzerland). The
MS transfer line temperature was 275 ◦C. The column was
a 50m VF-5MS (0.20mm I.D., 0.33mm df) (Varian, Sint-
Katelijne-Waver, Belgium). Helium was used as the carrier
gas at a constant flow rate of 1ml/min. 5ml of the final
extract in nonane were injected into a PTV injector ramped
as follows: 40 ◦C for 3min, at 720 ◦C/min to 320 ◦C for
4min, at 720 ◦C/min to 330 ◦C for 43min. The oven tem-
perature program was: 60 ◦C for 1.5min, at 70 ◦C/min to
200 ◦C, at 3.2 ◦C/min to 235 ◦C for 1.5min, at 3.2 ◦C/min to
270 ◦C for 10min, and at 15 ◦C/min to 310 ◦C for 13min.
The HRMS instrument was operated in SIM mode at a
minimum mass resolution of 10 000. The ion source tem-
perature was 270 ◦C and the EI energy was 40 eV. Additional
GC andHRMSparameters, including performing conditions,
followed isotope ratio checks and quantifying ions, and qual-
ity control for measurements were as described previously
[23].
2.3.1.2. Mono-ortho-PCBs and indicator PCBs. Concen-
trations were measured on an MAT95XL (Thermofinni-
ganMAT, Bremen, Germany) coupled to an Agilent 6890
Series (Palo Alto, CA, USA) gas chromatograph equipped
with an A200SE autosampler (CTC Analytics). The MS
transfer line temperature was 275 ◦C. The column was a
25m HT-8 (0.22mm I.D., 0.25mm df) (SGE, Austin, TX,
USA). Helium was used as the carrier gas at a constant
flow rate of 0.8ml/min. Two microlitres of the final extract
in nonane were injected into a split/splitless injector held
at 275 ◦C in splitless mode. The oven temperature pro-
gram was: 140 ◦C for 2min, at 15 ◦C/min to 220 ◦C for
7.5min, at 6 ◦C/min to 250 ◦C, at 2 ◦C/min to 260 ◦C, and
at 12 ◦C/min to 320 ◦C. The HRMS instrument was oper-
ated in SIM mode at a minimum mass resolution of 10 000.
The ion source temperature was 250 ◦C and the EI energy
was 50 eV. The ion dwell time ranged between 20 and
80ms, depending on the ionwindow. The inter-scan timewas
10ms.
2.3.2. GC–ID-QIST-MS/MS
2.3.2.1. PCDD/Fs and non-ortho-PCBs. Concentrations
were measured using a low resolution Finnigan PolarisQ ion
trap mass spectrometer (Austin, TX, USA). The separation
was performed on a 50m VF-5MS (0.20mm I.D., 0.33mm
df) (Varian). Helium was used as the carrier gas at a constant
flow rate of 1ml/min. Five microlitres of the final extract
in nonane were injected into a PTV injector ramped as fol-
lows: 140 ◦C for 0.1min, at 720 ◦C/min to 160 ◦C for 0.5min,
at 720 ◦C/min to 340 ◦C for 45min. The oven temperature
program was: 100 ◦C for 5min, at 52 ◦C/min to 210 ◦C, at
2.9 ◦C/min to 300 ◦C for 12min. Details on measured ions
are available elsewhere [11].
2.3.2.2. Mono-ortho-PCBs and indicator PCBs. concentra-
tions were measured on a low resolution GCQ (Finnigan).
Separation was performed on a 25m HT-8 (0.22mm I.D.,
0.25mm df) (SGE) column. Helium was used as the car-
rier gas at a constant flow rate of 0.8ml/min. 2ml of the
final extract in nonane were injected into a split-splitless
injector at 275 ◦C. The oven temperature program was:
140 ◦C for 2min, at 15 ◦C/min to 220 ◦C for 7.5min, at
6 ◦C/min to 250 ◦C, at 2 ◦C/min to 260 ◦C, at 12 ◦C/min to
320 ◦C.
The ion trap was connected by a heated transfer line
(300 ◦C) to a Thermoquest Trace GC 2000 (Milan, Italy)
gas chromatograph equipped with a Combi Pal autosampler
(CTCAnalytics). The ion source temperaturewas 210 ◦C and
the EI energy was 70 eV. The scan time was 250ms. Xcalibur
1.2 was used for data acquisition. Details are available in a
previous report [11].
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2.3.3. GC×GC–ID-TOF-MS
The GC×GC–TOF-MS instrument was the Pegasus 4D
(Leco, St Joseph, MI, USA). This system is based on a non-
moving quad-jet modulator consisting of two permanent cold
nitrogen jets and two pulsed hot-air jets, which are respon-
sible for the trapping and refocusing of compounds eluting
from the first dimension (1D) column. This modulator was
mounted in an Agilent 6890 GC oven and liquid nitrogen
was used to create the cold jets. The column set was made
of a 40m RTX-500 (0.18mm I.D., 0.10mm df) (Restek) in
the first dimension (1D) and a 1.5m BPX-50 (0.10mm I.D.,
0.10mm df) (SGE) in the second dimension (2D). The modu-
lationperiod (PM)was 4 s.Thehot pulse durationwas750ms.
Helium was used as the carrier gas at a constant flow rate of
0.8ml/min. 1.2ml of the final extract in nonane were injected
into a split/splitless injector held at 250 ◦C in splitless mode
and equipped with a press-tight Restek Uniliner. The pri-
mary oven was programmed as follows: 140 ◦C for 1min,
at 10 ◦C/min to 240 ◦C, at 1 ◦C/min to 260 ◦C for 5min, at
10 ◦C/min to 330 ◦C for 5min. The secondary oven tempera-
ture offset was 20 ◦C. The modulator temperature offset was
40 ◦C. The secondary oven temperature programwas: 160 ◦C
for 1min, at 10 ◦C/min to 260 ◦C, at 2.8 ◦C/min to 350 ◦C for
5min. TheMS transfer line temperature was 280 ◦C. The ion
source temperature was 250 ◦C with an EI energy of 70 eV.
The collected mass range was 100–550mm. The scan rate
was 60 scans/s and the detector voltage was 1800V. Data
processing and display of the GCxGC chromatograms were
achieved using integrated Leco ChromaTOF software, ver-
sion 2.10 (Pegasus Driver 2.12). Peak apexes were found
automatically and were further corrected manually when
required.
2.3.4. DR-CALUX
The DR-CALUX was developed by Wageningen Univer-
sity [19] and is distributed by BioDetection System (BDS,
The Netherlands). This assay consists of the rat hepatoma
H4IIE cell line stably transformed with an AhR controlled
luciferase reporter gene construct. Analyses were performed
by exposing the cells (triplicates, 96-well plates) during 24 h
to sample extracts and to 2,3,7,8-TeCDD standard solutions
in DMSO diluted in culture medium (a-MEM, Invitrogen,
Merelbeke,Belgium) containing10%(v/v) of fetal calf serum
(FCS, Invitrogen). The final concentration of DMSO in cul-
ture medium was 0.4% (v/v) for fish and milk samples and
1% for the pork sample. After cell lysis and substrate addition
[buffer containing 0.01% (w/v) luciferin (Promega, Charbon-
nieres, France) and 0.5mM ATP (Roche Diagnostics, Vilvo-
orde, Belgium)], luminescence was measured using a lumi-
nometer Orion II (Berthold Detection System, Pforzheim,
Germany).DR-CALUXconcentrationswere calculated from
a standard calibration curve, ranging from 0 (blank DMS0)
to 20 pg 2,3,7,8-TeCDD/well, and established in triplicate on
each 96-well plate. Dose response curves were fitted using
a user-defined curve fit. See previous report for full details
[30].
3. Results and discussion
3.1. Optimization of GC×GC separation
GC×GC separation had been optimized to enable the
seven 2,3,7,8-substituted PCDDs, ten 2,3,7,8-substituted
PCDFs, four non-ortho-PCBs, eight mono-ortho-PCBs, and
six indicator PCBs (Aroclor 1260) to be separated in a sin-
gle injection. However, we decided to consider two sepa-
rate injections for the present study for two reasons: firstly,
because we knew from a previous method development
exercise [18] that data handling and processing were major
issues for the GC×GC–TOF-MS instrument and secondly,
because the sample preparation we use produces two sepa-
rate fractions (the first one containing indicator PCBs and
mono-ortho-PCBs, the second one containing the PCDD/Fs
and non-ortho-PCBs). This permitted a reduction in data
processing time to less than 2min per calibration stan-
dard, when computing the calibration curves, and a reduc-
tion in real sample processing time to less than 10min.
The data files were around 120Mb for each processed
sample, although separated PCB and PCDD/F calibration
files still required multiple 4.7Gb-DVD session space for
backup.
From among the various column combinations reported
earlier for PCBs anddioxin analyses [31–34], a 1Dcarborane-
based dimethyl polysiloxane stationary phase [35] was cou-
pled to a 2D medium polarity 50% phenyl polysilphenylene-
siloxane phase of lower diameter and lower film thickness
than 1D. The high thermal stability of those two phases
allowed work at temperatures as high as 370 ◦C, ensuring the
production of narrow 2Dpeaks with 150ms and 60ms of peak
width at the base and at half height, respectively. Under opti-
mized conditions (see Section 2: Experimental procedures),
three to four 2D peaks were produced for each analyte after
modulation (PM = 4 s).
Figs. 1 and 2 illustrate the chromatographic distribution
of analytes into the GC×GC separation space. One can see
the successful separation of PeCB-123 and PeCB-118. Those
two congeners have different toxic equivalence to 2,3,7,8-
TCDD [2] and must be reported separately. Additionally, in
the case of fish, for which the bioaccumulation pathway is
known to be different from terrestrial species, another crit-
ical PCB separation was attained. HxCB-163 (not included
in the monitoring set of congeners) was chromatographically
separated from HxCB 138 (Aroclor 1260). Details concern-
ing the elution pattern of PCBs on a GC×GC column set
consisting of a 1D carborane based dimethyl polysiloxane
phase and a 2D 50% phenyl polysilphenylene-siloxane phase
are available in a previous report [36].
In Fig. 2, the elution of the 17 PCDD/Fs and of the 4 non-
ortho-PCBs is illustrated. The hexa-chlorinated congeners
(3 PCDDs and 4 PCDFs) were baseline-separated with the
exception of 1,2,3,4,7,8-HxCDF and 1,2,3,6,7,8-HxCDF for
which attention was needed for the assignment of potentially
overlapping 2D peaks. As illustrated in Fig. 3, two 2D peak
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Fig. 1. GC×GC–ID-TOF-MS contour plot of a standard solution containing a mixture of the six indicator-PCBs, two non-ortho-PCBs, the eight mono-ortho-
PCBs, and TeCB-80 at a concentration of 40 pg/ml. RIC based on the following ions: m/z 258 + 294 + 326 + 360 + 394× 4 + 304× 4.
Fig. 2. GC×GC–ID-TOF-MS contour plot chromatogram of a standard solution containing a mixture of seven 2,3,7,8-substituted PCDDs, ten 2,3,7,8-
substituted PCDFs, four non-ortho-PCBs, as well as TeCB-80 and 1,2,3,4-TCDD in a concentration range from 2.0 to 300 pg/ml. RIC based on the following
ions: m/z 28× 3 + 304 + 334× 3 + 318× 2 + 368× 3 + 352× 3 + 338 + 372 + 402× 3 + 386× 3 + 436× 3 + 420× 4 + 472× 3 + 456× 3.
J.-F. Focant et al. / J. Chromatogr. A 1086 (2005) 45–60 51
Fig. 3. GC×GC–ID-TOF-MSpeak clusters of [13C]1,2,3,4,7,8-HxCDF (X)
and [13C]1,2,3,6,7,8-HxCDF (Z) at a level of 125 pg in a standard solution.
clusters (X and Z) can be defined to describe the two com-
pounds. This, however, requires manual peak assignment to
ensure that X4 and Z1 are seen as part of different clus-
ters. Not only are the first dimension retention time (1tR)
and second dimension retention time (2tR) similar, but the
mass spectra are also identical for 1,2,3,4,7,8-HxCDF and
1,2,3,6,7,8-HxCDF. Consequently, the two traces cannot be
automatically deconvoluted. For standard solutions, this was
the only situation for which manual input was necessary to
ensure proper 2D peak combination and assignment. The
chromatographic separation was in agreement with the Euro-
pean Commission Directive 2002/69/EC [6], which requires
less than 25% of peak overlapping for these two hexa-
chlorinated furans. The case of OCDD and OCDF illustrates
the efficiency of the 2D phase in separating those two com-
pounds that co-elute in 1D.
3.2. Calibration of the GC×GC–ID-TOF-MS setup
For mono-ortho-PCBs and indicator PCBs, the concen-
tration of calibration standards ranged from 0.4 to 140 pg/ml
for the 12C-native compounds, with a constant concentra-
tion of 20 pg/ml for the corresponding 13C-labels. Each of
the analytes had its own internal standard. For all analytes,
the 0.4 pg/ml standard always gave a signal-to-noise (S/N)
ratio of greater than 5. As illustrated in Table 1, two ions
were summed for quantification of all compounds (natives
and labels). The couple [M+ 2] and [M+ 4]was selected in all
cases, except for TriCBs, TeCBs, 2,3,7,8-TeCDF, and 2,3,7,8-
TeCDD, where [M] and [M+ 2] ions were used. For the low
end of the calibration curve, only one 2D peak was produced,
due to the small amount of compound. Relative response fac-
tors (RRFs) ranged from 0.91 to 1.2, with the larger deviation
from the unit value observed for the lowest part of the con-
centration range. As in the case of unknown samples, isotope
ratios of the selected quantification ions were compared to
theoretical values (Table 1). A deviation of 20% from the
theoretical value was accepted for the data to be validated.
PCDD/F and non-ortho-PCB calibration standard con-
centrations differed depending on analytes. A complete list
of the standards has been reported previously [23]. The
dynamic working range was 0.5–7.5 pg/ml, 0.2–35 pg/ml,
0.5–7.5 pg/ml, 1–10 pg/ml, 1–7.5 pg/ml, 1.25–25 pg/ml,
5–25 pg/ml, 10–100 pg/ml, 2–7.5 pg/ml, and 50–500 pg/ml,
for TeCDF, TeCDD, PeCDFs, PeCDD, HxCDFs, HxCDDs,
HpCDFs, HpCDD, OCDF, and OCDD, respectively. RRF
values ranged from 0.89 to 1.32. For PCDD/Fs, the minimum
accepted S/N value was decreased to 2. Signals greater than
2, with a calculated isotope ratio inside the accepted 20%
deviation range, were considered as valid. The dynamic
working range for non-ortho-PCBs was 4–80 pg/ml, with
RRF values from 0.97 to 1.03 for PeCB-126 and HxCB-169,
and 1.12 to 1.29 for TeCB-77 and TeCB-81, for which blank
levels were elevated in the laboratory during the time that
the project was running.
During the study, two independent sets of calibrations
were produced for both groups of compounds. The first order
linear calibration curves were forced to origin for all com-
pounds.Most of the correlation coefficients were greater than
0.999. The unknown samples were split into two series of
triplicates; each series was quantified against a different cal-
ibration curve.
3.3. Comparison of congener-specific methods
As for GC–ID-HRMS and GC–ID-QIST-MS/MS, ID
based on the use of 13C-labelled compounds was used for
quantification. The ratios of 12C-native areas over 13C-label
areas were calculated and corrected by RRF values issued
from the calibration curve calculations. The major difference
using GC×GC–ID-TOF-MSwas that areas of 2–4 2D peaks
had to be summed up prior to quantification. This exercise
significantly increases the processing and reviewing time,
but is important for accurate quantification [18]. To reduce
the influence of sample extraction and clean-up on the com-
parison exercise, the same sample sizes were extracted and
identical sample preparation steps were performed for the
three MS techniques.
Recovery rates, based on the addition of recovery (sur-
rogate) standards prior to GC–MS injection, were therefore
similar for all methods. They complied with the requirements
of the European Commission Directive 2002/69/EC [6], in
which a range of 60–120% has been defined for confirma-
torymethods and a range of 30–140% for screeningmethods.
AlthoughGC–ID-QIST-MS/MSandGC×GC–ID-TOF-MS
are strictly defined as screening methods in the Directive,
recovery rates ranged in the interval defined for confirmatory
methods. Blank (BC) analyses were performed by carrying
out the entire analytical procedure to which unknown sam-
ples were exposed. Because BC levels are mainly dependent
on sample preparation procedure, levels were similar and no
significant influences of MSmeasurement on BC levels were
recorded during the study. All data reported here were BC-
corrected.
In order to compare the responsiveness of the three MS-
based methods without any sample matrix influence, an
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Table 1
Principal chromatographic and mass spectrometric parameters for the GC×GC–ID-TOF-MS separation of the selected PCBs and PCDD/Fs
Peak number Congenera 1tR (s) 2tR (s) Quantification masses Theoretical isotope
ratios
Acceptable
range (20%)12C12-natives 13C12-labels
1 TriCB-28 727 1.91 258 256 270 268 0.98 0.78–1.18
2 TeCB-52 751 2.09 290 292 302 304 0.77 0.62–0.92
3 TeCB-80b 895 2.11 – – 302 304 0.77 0.62–0.92
4 PeCB-101 923 2.34 328 326 340 338 0.65 0.52–0.78
5 TeCB-81 1025 2.27 290 292 302 304 0.77 0.62–0.92
6 TeCB-77 1061 2.32 290 292 302 304 0.77 0.62–0.92
7 PeCB-123 1094 2.56 328 326 340 338 0.65 0.52–0.78
8 PeCB-118 1106 2.56 328 326 340 338 0.65 0.52–0.78
9 PeCB-114 1126 2.69 328 326 340 338 0.65 0.52–0.78
10 HxCB-153 1150 2.57 362 360 374 372 0.82 0.66–0.98
11 PeCB-105 1186 2.79 328 326 340 338 0.65 0.52–0.78
12 HxCB-138 1233 2.81 362 360 374 372 0.82 0.66–0.98
13 1,2,3,4-TeCDDb,c 1252 2.56 – – 328 – – –
14 2,3,7,8-TeCDF 1264 2.56 304 306 316 318 0.77 0.62–0.92
15 2,3,7,8–TeCDD 1292 2.46 320 322 332 334 0.76 0.61–0.91
16 PeCB-126 1340 2.46 328 326 340 338 0.65 0.52–0.78
17 HxCB-167 1381 2.69 362 360 374 372 0.82 0.66–0.98
18 HxCB-156 1476 2.84 362 360 374 372 0.82 0.66–0.98
19 HxCB-157 1496 2.89 362 360 374 372 0.82 0.66–0.98
20 HpCB-180 1512 2.81 396 394 408 406 0.98 0.78–1.18
21 1,2,3,7,8-PeCDF 1559 2.61 342 340 354 352 0.65 0.52–0.78
22 2,3,4,7,8-PeCDF 1675 2.61 342 340 354 352 0.65 0.52–0.78
23 1,2,3,7,8-PeCDD 1691 2.54 358 356 370 368 0.66 0.53–0.79
24 HxCB-169 1711 2.42 362 360 374 372 0.82 0.66–0.98
25 HpCB-189 1875 2.76 396 394 408 406 0.98 0.78–1.18
26 1,2,3,4,7,8-HxCDF 2025 2.52 376 374 388 386 0.82 0.66–0.98
27 1,2,3,6,7,8-HxCDF 2037 2.54 376 374 388 386 0.82 0.66–0.98
28 1,2,3,4,7,8-HxCDD 2185 2.42 392 390 404 402 0.82 0.66–0.98
29 1,2,3,6,7,8-HxCDD 2197 2.42 392 390 404 402 0.82 0.66–0.98
30 2,3,4,6,7,8-HxCDF 2209 2.46 376 374 388 386 0.82 0.66–0.98
31 1,2,3,7,8,9-HxCDD 2264 2.37 392 390 404 402 0.82 0.66–0.98
32 1,2,3,7,8,9-HxCDF 2296 2.54 376 374 388 386 0.82 0.66–0.98
33 1,2,3,4,6,7,8-HpCDF 2436 2.39 410 408 422 420 0.98 0.78–1.18
34 1,2,3,4,6,7,8-HpCDD 2519 2.46 426 424 438 436 0.98 0.78–1.18
35 1,2,3,4,7,8,9-HpCDFb 2543 2.69 – – 422 420 0.98 0.78–1.18
36 OCDD 2703 2.94 458 460 470 472 0.88 0.70–1.05
37 OCDF 2707 3.15 442 444 454 456 0.88 0.70–1.05
a Numbering of PCBs, according to IUPAC.
b Congeners used for recovery calculation.
c This congener is 13C6-1,2,3,4-TeCDD only.
unknown standard solution containing all the target ana-
lytes had been analyzed. Table 2 presents the mean values
issued from two sets (triplicates) of measurements performed
against two independent sets of calibration data. Results
from GC–ID-HRMS measurements were set as the refer-
ence data to which the GC×GC–ID-TOF-MS and GC–ID-
QIST-MS/MS methods were compared. For PCDD/Fs, the
precision of the three measurements methods was similar,
with RSD ranges of 0.6–11%, 1.4–12.9%, and 2.5–9.5% for
GC–ID-HRMS, GC×GC–ID-TOF-MS, and GC–ID-QIST-
MS/MS, respectively. In the case of PCBs, RSD ranges
were even lower for GC–ID-HRMS and GC×GC–ID-TOF-
MS, with values of 0.9–3.5% and 0.9–5.8%, respectively.
GC–ID-QIST-MS/MS seemed to suffer from a lower preci-
sion, with an RSD range of 2.1–16.3% but, for most of the
analytes, the precision still complied with the maximal value
of 15%, described in the EU recommendations for confirma-
tory methods [6]. Both GC×GC–ID-TOF-MS and GC–ID-
QIST-MS/MS were within the range of 80–110% compared
with the GC–ID-HRMS reference values. No explanation for
the low OCDF GC×GC–ID-TOF-MS response case has yet
been found and is still under investigation.
Real fish, pork, and milk samples were analyzed. Fig. 4
illustrates the results for the non-ortho and mono-ortho-
PCBs. These PCBs are the ones that express similar toxicity
pathways to 2,3,7,8-TCDD and that contribute to the toxic
equivalence (TEQ) calculation [2]. They usually contribute
between one third and one half of the 2,3,7,8-TeCDD-like
toxicity in foodstuff samples. From Fig. 4, it appears that
all methods performed similarly for the three investigated
matrices independent of the levels. Lower RSDs were repro-
ducibly observed for the reference GC–ID-HRMS method.
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Table 2
Comparison betweenGC–ID-HRMS,GC×GC–ID-TOF-MSandGC–ID-QIST-MS/MS for themeasurement of the selected PCBs andPCDD/Fs in an unknown
standard solution
Congenera pg/g
solution
GC–ID-HRMS GC×GC-ID-TOF-MS Relative to
GC–ID-HRMS
(%)b
GC–ID-QIST-
MS/MS
Relative to
GC–ID-HRMS
(%)b
Mean RSD (%) Mean RSD (%) Mean RSD (%)
2,3,7,8-TeCDD 18.7 2 14.9 12 80 16.9 6 91
1,2,3,7,8-PeCDD 22.2 4 24.6 1 111 21.5 9 97
1,2,3,4,7,8-HxCDD 9.5 5 7.9 12 83 8.2 5 86
1,2,3,6,7,8-HxCDD 24.4 3 23.3 10 96 27.9 9 114
1,2,3,7,8,9-HxCDD 16.0 1 13.6 7 85 13.8 5 86
1,2,3,4,6,7,8-HpCDD 34.4 1 26.3 4 76 31.9 6 93
OCDD 107.3 3 92.6 10 86 108.5 5 101
2,3,7,8-TeCDF 16.3 1 12.9 12 79 13.8 2 85
1,2,3,7,8-PeCDF 11.8 2 9.1 4 77 11.1 4 95
2,3,4,7,8-PeCDF 44.9 2 35.3 7 79 36.5 4 81
1,2,3,4,7,8-HxCDF 10.3 1 9.1 5 89 8.8 6 86
1,2,3,6,7,8-HxCDF 31.4 2 23.4 7 75 24.5 9 78
1,2,3,7,8,9-HxCDF 7.7 3 5.9 3 77 6.1 7 79
2,3,4,6,7,8-HxCDF 14.5 1 12.2 13 84 14.1 9 97
1,2,3,4,6,7,8-HpCDF 16.1 1 17.1 8 106 16.2 5 100
1,2,3,4,7,8,9-HpCDF 22.4 11 – – – 21.5 4 96
OCDF 35.0 1 21.6 6 62 30.4 4 87
TeCB-77 243.0 1 222.5 3 92 226.6 4 93
TeCB-81 26.2 1 23.9 2 91 24.9 4 95
PeCB-126 74.9 1 68.2 2 91 69.7 2 93
HxCB-169 22.5 3 21.6 6 96 21.4 2 95
PeCB-105 111.7 1 104.1 1 93 109.7 6 98
PeCB-114 33.2 2 30.4 3 92 30.5 15 92
PeCB-118 224.4 3 197.7 1 88 238.5 8 106
PeCB-123 55.1 1 52.4 4 95 51.0 7 93
HxCB-156 44.7 4 43.0 2 96 41.8 11 94
HxCB-157 33.6 2 31.2 1 93 31.8 6 94
HxCB-167 33.2 3 31.6 4 95 29.2 5 88
HpCB-189 54.7 1 47.3 1 86 46.5 16 85
TriCB-28 392.7 1 351.6 3 90 360.6 7 92
TeCB-52 229.9 1 223.4 1 97 226.1 9 98
PeCB-101 233.8 2 226.7 0 97 192.1 13 82
HxCB-138 146.6 1 147.5 3 101 129.6 10 88
HxCB-153 239.8 1 236.2 1 99 215.2 8 90
HpCB-180 283.9 1 254.4 6 90 318.2 5 112
a Numbering of PCBs according to IUPAC.
b Ratio calculated by dividing the GC×GC–ID-TOF-MS (or GC–ID-QIST-MS/MS) values by the reference GC–ID-HRMS values times 100.
Measurements of the six indicator PCBswere also performed
on these samples. The method comparison exercise did not
indicate any significant differences between the three MS-
basedmethods. Concentrations ranged from500 to 6000 pg/g
fresh weight (fw) for fish, from 600 to 12,000 pg/g fw for
pork, and from 30 to 70 pg/g fw for milk (data not shown).
Such levels are well above the instrumental LODs for the
alternative methods that were characterized by similar RSDs
to GC–ID-HRMS (2–15%). One should, however, mention
that, due to the low sample intake and the large variations in
blank levels, TriCB-28 and TeCB-52 were below the limits
of quantification (LOQs) for all methods in the case of pork
and milk.
For PCDD/Fs (Fig. 5), levels in the unfortified matri-
ces were much lower than for PCBs and can be consid-
ered as the background levels currently encountered in the
EU. For fish, because of the relatively high levels and
the relatively large sample sizes (15 g), both GC×GC–ID-
TOF-MS and GC–ID-QIST-MS/MS compared well with
GC–ID-HRMS. However, although the RSDs for GC–ID-
HRMS were 7–14%, GC×GC–ID-TOF-MS and GC–ID-
QIST-MS/MS RSDs ranged from 10 to 60% and from 5 to
30%, respectively. In practice, such concentrations were very
close to the lower end of theworking range defined by the cal-
ibration standards and on the edge of the LOQs. For example,
the 15 g sample size and the 0.4 pg/g fw level of 1,2,3,7,8-
PeCDF represent 1.1 pg of compound injected (75% recovery
rates, 1.2ml injected out of 5ml). Fig. 6 illustrates how low the
signal for such levels can be regarding the total ion current
and the 13C-labelled compounds. Three modulation cycles
(PM = 4 s) are represented. The signal in Fig. 6A is based on
the TIC and is mainly a result of matrix interferences still
present after the sample preparation procedure. Fig. 6B is
the reconstructed ion current (RIC) based on the ions of the
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Fig. 4. Comparison of GC–ID-HRMS with GC×GC–ID-TOF-MS and GC–ID-QIST-MS/MS for the measurement of non-ortho and mono-ortho-PCBs in
fish (A), in pork (B), and in milk (C) samples (n= 6).
label compound (m/z 352 + 354) at a concentration of approx-
imately 85 pg (10ml of a 50 pg/ml standard solution, 75%
recovery rates, 1.2ml injected out of 5ml). Fig. 6C is the RIC
of the native (12C) 1,2,3,7,8-PeCDF (1.1 pg), only one 2D
peak was obtained because of the very low level. That native
peak signal was several orders of magnitude lower than the
TIC trace. Increasing sample sizes is not feasible in practice
because the larger the sample size, the larger the quantities
of solvents and sorbents, the higher the BC levels, and the
higher the LOQs.
Conversely, in some cases, large standard deviation might
be attributed to the fact that the system was measuring out-
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Fig. 5. Comparison of GC–ID-HRMS with GC×GC–ID-TOF-MS and GC–ID-QIST-MS/MS for the measurement of PCDD/Fs in fish (A), in pork (B), and
in milk (C) samples (n= 6).
side the working range. This is the case for 2,3,7,8-TeCDF
for which the 3.1 pg/g fw values represent 8.4 pg injected
(15 g sample size, 75% recovery rates, 1.2ml injected out
of 5ml), although the highest point of calibration was 7.5 pg.
Increasing the sample sizewould accentuate the problem.The
calibration standard concentrations were selected to cover as
much as possible of the working range but out-of-calibration
situations can always arise, depending on the congener dis-
tribution in the sample. From this study, it appeared that
GC×GC–ID-TOF-MS was more affected by this type of
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Fig. 6. GC×GC–ID-TOF-MS raw chromatogram for 1,2,3,7,8-PeCDF in
a fish sample. (A) TIC trace, (B) RIC trace for the 13C label, and (C) RIC
trace for the native (1.1 pg injected).
out-of-calibration situation. In the case of pork (30 g sample
size) and milk (130 g sample size), which are characterized
by low background levels, the RSDswere higher (up to 90%).
Such variations were not acceptable. Despite the poor preci-
sion, the congener distribution was still well defined for all
matrices and can be used to describe specific matrix patterns
for contamination source tracking or fingerprinting of sets of
samples.
3.4. Comparison of methods on a TEQ basis
Because all congeners do not express the same toxic-
ity, results of dioxin and dioxin-like compound analyses are
commonly reported in terms of 2,3,7,8-TCDD TEQs [2].
Regulations on admissible levels in foodstuffs are based on
sampleTEQvalues [1].Data issued from theMS-basedmeth-
ods can be converted into TEQs using toxic equivalent factor
(TEF) tables [2].
As mentioned earlier, for regulation purpose, global mea-
surement can also be made using bioassays, such as the
DR-CALUXassay. In this case, a global response is obtained.
The same fish, pork, and milk samples were run on the
DR-CALUX (two independent sets of replicates) and data
were compared to the reference GC–ID-HRMS results. All
reported DR-CALUX results met the following basic quality
criteria: for the 2,3,7,8-TeCDD calibration curve, the maxi-
mum induction factor was at least six-fold, the EC50 value
was in the range 0.4–2.4 pg TeCDD/well, R2 of the fitted
curve was > 0.98, and the RSDs of the mean of the rela-
tive light units (RLU) measured in triplicate was <15%. For
samples, the sample response was below the response corre-
sponding to the 2,3,7,8-TeCDD EC50 and RSDs were <30%,
as required by the European guidelines [6]. The quantifica-
tion limits were 0.08, 0.02 and 0.03 pg DR-CALUX TEQ/g
product for fish, pork and milk, respectively.
As shown in Fig. 7, a large discrepancy appeared between
the GC–ID-HRMS data and the raw DR-CALUX data. The
biological method clearly and systematically underestimated
the total TEQ (PCDD/Fs and dioxin-like PCBs) concentra-
tions in each case. For the biological measurement, because
the use of ID based on 13C-labelled internal standards is not
possible, it is difficult to account for the loss of analytes dur-
ing the sample preparation procedure and an underestimation
of sample burden is likely to happen. Two approaches were
investigated to correct the raw DR-CALUX data.
First, the biological data were corrected by a factor tak-
ing into account the ratio between results obtained for a well
characterized fortified (PCDD/Fs and dioxin-like PCBs) beef
fat quality control (QC) sample included in both GC–ID-
HRMS and DR-CALUX series. This spiked beef fat QC
contained 3.1 pg WHO-TEQ per g (34% of PeCB-126, 17%
of PeCDD, 17% of TeCDD, 9% of 2,3,4,7,8 PeCDF), as
measured by GC–ID-HRMS, and an average of 1.8 pg DR-
CALUX TEQ/g. This significant variation accounted for the
rather large difference we reported earlier [30] between the
relative potencies (REP) of WHO-TEF and the DR-CALUX
for PeCB-126 and PeCDD, two major components of the QC
sample. TheQCcorrectedDR-CALUX thus gets closer to the
reference GC–ID-HRMS data but the trend of underestima-
tion was still present for all samples. Additionally, because
the QC samples consisted of fat, they were not submitted to
the entire sample preparation procedure (no extraction step
required). Therefore, correcting raw DR-CALUX data using
a factor based on this fat QC did not account for potential
analyte losses during the extraction step.
The second approach was based on the use of matrix-
specific reference samples for raw DR-CALUX data cor-
rection. Each reference sample followed unknowns through
the entire matrix-specific sample preparation procedure. This
constitutes a better approach because similar congener dis-
tributions, and thus similar assay responses, can be expected
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Fig. 7. Raw and corrected responses of the DR-CALUX assay versus GC–ID-HRMS for the investigated samples.
in identical matrices. Also, because the reference value is
calculated by GC–ID-HRMS, having a matrix specific ref-
erence sample helps to reduce the effect of the differences
between TEFs and REPs. The ratio of the total TEQ (sum of
PCDD/Fs and dioxin-like PCBs) concentration measured by
GC–ID-HRMS over the DR-CALUX response was used as a
correction factor applied to the rawDR-CALUXdata.Results
for the congener-specific GC–ID-HRMS measurement of
those DR-CALUX matrix-specific reference samples were
the following: for the fish reference sample, 42% of PeCB-
126, 27%of 2,3,4,7,8-PeCDFand 10%of 2,3,7,8-TeCDF; for
the pork reference sample, 24% of 2,3,4,7,8-PeCDF, 15% of
PeCB-126, 11% of 2,3,7,8-TeCDD, 10% of both HxCB-156
and 157; for the milk reference sample, 40% of PeCB-118,
28% of PeCB-126, and 9% of 2,3,4,7,8-PeCDF. Both pork
andfish reference samples had a congener profile correspond-
ing to a classical background contamination (similar to the
pattern of the analyzed sample) and good correlations with
the GC–ID-HRMS data were observed (Fig. 7). The situation
was not as good for milk because the pattern observed in the
reference sample (PeCB-118 was unusually high) was dif-
ferent from a classical background congener distribution for
milk and this influenced the raw data correction, as though
a non-matrix specific reference sample had been used. The
direct consequence led to an unexpected low recovery for the
milk sample, inducing an over-estimation of the corrected
DR-CALUX data.
Fig. 8 summarizes the comparison of all methods in terms
of TEQs. Quite surprisingly, although we previously pointed
outmuch higher variations in theGC×GC–ID-TOF-MS and
GC–ID-QIST-MS/MS responses for PCDD/Fs on a congener
basis, as well as the difficulty for those methods to detect the
low pg levels of analytes, the TEQ results compared favor-
ably with GC–ID-HRMS (lower part in the bar graph in
Fig. 8). In fact, a rather good description of the TEQ contrib-
utors (2,3,7,8-TCDD [TEF= 1], 1,2,3,7,8-PeCDD [TEF= 1],
2,3,4,7,8-PeCDF [TEF= 0.5], see [2] for complete list of the
TEFs) was achieved using the alternative methods. The PCB
contribution to the TEQ was similar for the three MS-based
methods. The lower GC×GC–ID-TOF-MS value for pork
was due to the lower reported concentration for PeCB-126,
the most important PCB contributor (TEF= 0.1) to the TEQ.
The MS-based method TEQs and the DR-CALUX reference
sample corrected TEQ compared well (see earlier for milk
discrepancy), althoughDR-CALUXRSDswere significantly
higher (10–28%), which is acceptable for a screeningmethod
[6].
From a practical point of view, the slight variations
observed around the reference GC–ID-HRMS value for the
alternative methods can have important consequences. For
example, themaximumacceptable level for PCDD/Fs inmilk
has been set at 3 pg PCDD/F TEQ/g on a lipid basis in the
EU [1]. If one lipid corrects the data (3.3% lipids, gravimetri-
Fig. 8. TEQ comparison of GC–ID-HRMS with GC×GC–ID-TOF-MS,
GC–ID-QIST-MS/MS, and DR-CALUX (reference sample corrected) for
themeasurement of PCDD/Fs (bottom part) and dioxin-like PCB (non-ortho
and mono-ortho-PCBs) (upper part) for the investigated samples.
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cally measured by six replicates), the concentrations become
2.77± 0.18 pg/g lipid weight (lw), 2.98± 0.94 pg/g lw,
3.52± 0.52 pg/g lw, and 11.91± 2.92 pg/g lw, for GC–ID-
HRMS, GC×GC–ID-TOF-MS, GC–ID-QIST-MS/MS, and
DR-CALUX, respectively. Of course, milkDR-CALUXdata
are known to be subject to reference sample-related prob-
lems in the present study and the number also includes the
response due to PCB content, although the regulation is based
on PCDD/Fs only. But, for the MS-based techniques, the
numbers could be used as such to check compliance with
regulations, and the difference between those numbers might
constitute a critical situation for decision makers. Currently,
a sample is defined as non-compliant with the regulation
maximum level if the measured value exceeds the maxi-
mum level beyond a reasonable doubt, taking into account
measurement uncertainty [37]. In other words, the measured
value minus the estimated uncertainty (including additional
parameters than just the RSDs issued from multiple mea-
surements) must be above the regulation level for the sample
to be declared non-compliant [38]. In the example of the
milk, GC–ID-HRMS and GC×GC–ID-TOF-MS measure-
mentswould clearly define the sample as compliant, although
GC–ID-QIST-MS/MS would conduct to an uncomfortable
situation, right on the edge of non-compliance for the sam-
ple.
3.5. Comparison of method costs
A cost estimate can be drawn for the different methods
based on the following: 1000 unknown samples to be run
yearly, including scientist employment, instrumentation pur-
chase and paying-off (5 Years), reagents, sample preparation,
ID standards, consumables, technology licensing and royal-
ties (DR-CALUX), and costs relating to the incorporation of
the required amounts of blanks and quality control samples in
the series of unknowns. The cost estimate can vary, depending
on several additional parameters, but the relative comparison
of the methods presented here is based on similar operat-
ing conditions and parameters (DR-CALUX cost is based on
duplicate sample measurement). In Table 3, a relative cost
comparison is shown and indicates that the costs involved in
alternative techniques are not much lower than for GC–ID-
HRMS. A closer look indicates that the cost distribution is,
however, different. In fact, for the three alternative meth-
ods, if the cost contribution related to the measurement itself
Fig. 9. GC×GC–ID-TOF-MS apex plot based on the retention data of the
37 compounds.
is reduced, the cost for scientific employment is increased.
Using potentially more simple (cheaper) measurement tech-
nologies seems to result in higher human input requirements
(data processing, reviewing, and reporting).
In the case of GC×GC–ID-TOF-MS, Table 3 data are
based on two separate injections, one for PCDD/Fs and non-
ortho-PCBs, and one for mono-ortho-PCBs and indicator
PCBs (see chromatograms in Figs. 1 and 2). The instrumental
time can be compressed and the method simplified by per-
forming multi-group analyte measurement, a single injection
for the measurement of all analytes of interest instead of two
separate injections. The apex plot in Fig. 9 illustrates the ana-
lyte distribution inside the chromatographic area. The apex
plot was created by combining the separate injection data
to demonstrate the separation efficiency when the 37 com-
pounds of interest are grouped together. The distribution of
the two groups of compounds in the chromatographic space
can be defined as bimodal with slight overlap between the
groups of PeCBs and TeCDD/Fs (see Table 1 for numbering
correspondences). Therefore, no additional co-elution prob-
lems are recorded when pooling the two sets of analytes in a
single injection. The total run time can then be 45min for the
separation of all 37 analytes (0.8 analyte per min). Currently,
due to the complexity of the GC×GC–ID-TOF-MS data,
this multi-analyte approach requires much larger processing
and manual data reviewing time than the multiple injection
approach. The classical manual data reviewing process for
a real low level sample can still require up to several hours
Table 3
Estimated percent distribution of the cost of the various stages of the measurement methods in the case of feed samples
GC–ID-HRMS GC×GC–ID-TOF-MS GC–ID-QIST-MS/MS DR-CALUXa
Scientist employment 23 35 35 36
Extraction 11 8 11 7
Clean-up 28 27 33 29
Measurement 38 30 21 8
Licensing and royalties – – – 20
Cost per sample (relative) +++++ +++++ ++++ +++
a Cost based on duplicate measurements.
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to be completed accurately. However, once those steps are
as automated and as rigorous as for classical GC–MS, the
expense related to highly skilled labor will fall and the over-
all price of thismethod can be expected to be reduced by up to
one third. Newly available and upcoming software features
(e.g. raw TOF-MS data re-sampling), as well as enhanced
computer power, will help to go in that direction. One should
also keep in mind the comprehensive aspect of TOF-MS data
collection. Because TOF-MS does not operate in SIM mode,
all masses included in the defined mass range are collected.
This permits the screening of mass spectral data for other
compounds present in the same fractions afterwards, without
sample reprocessing or reinjection.
Although, in this study, all MS-based techniques used
automated sample preparation steps and DR-CALUX used
manual ones, the contribution of sample preparation to the
global cost is similar. The use of the DR-CALUX approach
does not offer congener-specific data and pattern descrip-
tion but permits the cutting of prices by half, making it the
most economically efficient screening method. Additionally,
because they fulfill the same quality control requirements and
offer as much data as does the GC–ID-HRMS, the alternative
GC×GC–ID-TOF-MS and GC–ID-QIST-MS/MS methods
should not strictly be considered as screening methods, but
as complementary methods.
4. Conclusions
The primary goal of the present study was to set up a
13C-labelled isotope dilution GC×GC-TOF-MSmethod for
the measurement of 17 PCDD/Fs and 18 PCBs in foodstuff
matrices. GC×GC–ID-TOF-MS showed its suitability to
accommodate the task and to offer at least as much qual-
ity control capability (isotope dilution quantification, isotope
ratio check, dual set of retention time check) asGC–ID-QIST-
MS/MS, another potential alternative to GC–ID-HRMS.
While not as many dioxin-dedicated samples have ever been
run on a GC×GC-TOF-MS instrument as on both GC–ID-
QIST-MS/MS and GC–ID-HRMS, the study showed that the
particularly large ion volume in the TOF-MS source makes
it unlikely to be as influenced by sample extract quality as
other classical small source types, a significant advantage for
routine use. Furthermore, the TOF-MS instrument showed
itself to be more robust than QIST-MS, where the ion trap
can easily be contaminated by matrix interfering ions, reduc-
ing sensitivity when used on a routine basis.
Although the measurement of PCBs is under control, fur-
ther improvement in sensitivity at the sub-picogram level,
together with reduced data handling and processing time
requirements are still needed in order for GC×GC-TOF-
MS to be set up as a true alternative to GC–ID-HRMS for
routine ultra-trace measurement of PCDD/F in challenging
foodstuffmatrices.Additionally,while the cost per sample for
GC×GC–ID-TOF-MS is currently still similar to GC–ID-
HRMS, reduction of human input for data handling will also
significantly reduce the cost and make this single injection
multi-group method an appealing approach to obtain a quick
and complete picture for all the 2,3,7,8-TeCDD toxicity-
related congeners.
When comparing the methods on a PCDD/F TEQ basis,
even if the differences are small, they could have impor-
tant consequences when considering the use of alternative
methods for measurement within the framework of a regula-
tion based on a single number. In that context, and until the
GC–ID-HRMS is considered as the referencemethod, results
issued from both MS-based and biological alternative meth-
ods should always be confirmed prior to decision-making
regarding compliance with the regulation. Establishing the
regulation based on an acceptable range, instead of a locked
value, could simplify the situation from an analytical point of
view, probably without significantly compromising the qual-
ity of our foodstuffs.
Finally, as planned in the near future, the integration of
PCBs into the EU regulation will help the DR-CALUX assay
and the related simple sample preparation scheme to become
truly the screening method of choice for global toxicity eval-
uation at a moderate cost. Both of the MS-based alternative
method are capable of describing PCBandPCDD/F congener
profiles with reasonable precision when source identification
is required for contamination tracking. GC×GC–ID-TOF-
MS and GC–ID-QIST-MS/MS could therefore be defined
as complementary methods to GC–ID-HRMS, rather than
screening methods. Aside from the method, the constant
decrease in foodstuff background levels, the proactive EU
approach based on action and target levels, aswell as plans for
future lower residue limits will require additional improve-
ments in LODs to ensure proper reporting.
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